The mission of the Genetic and Rare Diseases (GARD) Information Center is to help the rare disease community meet these common challenges. We do this by providing free access to reliable and easy-to-understand information.

We invite patients, family members, caregivers, and others seeking information about rare diseases to contact GARD by phone or through our contact form. Our Information Specialists provide personalized responses that are easy to understand, free of charge, and confidential.

GARD uses data collected from Orphanet and Online Mendelian Inheritance in Man (OMIM) to interpret and provide information on rare diseases. This includes names, synonyms, genes, symptom frequency, population estimates and more.

Currently, GARD aims to provide the following information for this disease: Population Estimate: Fewer than 50,000 people in the U.S. have this disease. Symptoms: May start to appear as a Newborn and as an Infant.

GARD uses data collected from Orphanet and Online Mendelian Inheritance in Man (OMIM) to interpret and provide information on rare diseases. This includes names, synonyms, genes, symptom frequency, population estimates and more.

Currently, GARD aims to provide the following information for this disease: Population Estimate: Fewer than 5,000 people in the U.S. have this disease. Symptoms: May start to appear during Pregnancy and as a Newborn.

Currently, GARD aims to provide the following information for this disease: Population Estimate: Fewer than 1,000 people in the U.S. have this disease. Symptoms: May start to appear as an Infant and as a Child.

GARD uses data collected from Orphanet and Online Mendelian Inheritance in Man (OMIM) to interpret and provide information on rare diseases. This includes names, synonyms, genes, symptom frequency, population estimates and more.

GARD uses data collected from Orphanet and Online Mendelian Inheritance in Man (OMIM) to interpret and provide information on rare diseases. This includes names, synonyms, genes, symptom frequency, population estimates and more.

Currently, GARD aims to provide the following information for this disease: Population Estimate: Fewer than 5,000 people in the U.S. have this disease. Symptoms: May start to appear as a Newborn and as an Infant.